...
首页> 外文期刊>Biomolecules >Creation of Cybrid Cultures Containing mtDNA Mutations m.12315GA and m.1555GA, Associated with Atherosclerosis
【24h】

Creation of Cybrid Cultures Containing mtDNA Mutations m.12315GA and m.1555GA, Associated with Atherosclerosis

机译:含有M.12315G> A和M.1555G> A,与动脉粥样硬化相关的含有M.12315G> A和M.1555G> A的糖培养物

获取原文
           

摘要

In the present work, a pilot creation of four cybrid cultures with high heteroplasmy level was performed using mitochondrial genome mutations m.12315GA and m.1555GA. According to data of our preliminary studies, the threshold heteroplasmy level of mutation m.12315GA is associated with atherosclerosis. At the same time, for a mutation m.1555GA, such a heteroplasmy level is associated with the absence of atherosclerosis. Cybrid cultures were created by fusion of rho0-cells and mitochondria from platelets with a high heteroplasmy level of the investigated mutations. To create rho0-cells, THP-1 culture of monocytic origin was taken. According to the results of the study, two cybrid cell lines containing mutation m.12315GA with the heteroplasmy level above the threshold value (25% and 44%, respectively) were obtained. In addition, two cybrid cell lines containing mutation m.1555GA with a high heteroplasmy level (24%) were obtained. Cybrid cultures with mtDNA mutation m.12315GA can be used to model both the occurrence and development of atherosclerosis in cells and the titration of drug therapy for patients with atherosclerosis. With the help of cybrid cultures containing single nucleotide replacement of mitochondrial genome m.1555GA, it is possible to develop approaches to the gene therapy of atherosclerosis.
机译:在本作工作中,使用线粒体基因组突变M.12315G> A和M.1555G> A和M.1555g> A和M.12315G> A和M.1555g> A.根据我们初步研究的数据,突变突变均匀突变水平M.12315G> A与动脉粥样硬化有关。同时,对于突变M.1555G> A,这种异质水平与缺乏动脉粥样硬化有关。通过血小板融合来产生胞胎培养物,从血小板与研究突变的高异素水平融合。为了产生rhO 10细胞,拍摄单核细胞的THP-1培养物。根据该研究的结果,获得含有突变M.12315G> A的含有突变水平高于阈值(分别为25%和44%)的两种胞胎细胞系。此外,获得了含有高异素水平(24%)的突变M.1555g> A的两条胞胎细胞系。具有M.12315G的胞胎培养物M.12315G> A可用于模拟细胞动脉粥样硬化的发生和发展,以及用于动脉粥样硬化患者的药物治疗的滴定。借助含有单核苷酸替代线粒体基因组M.1555G> A的胞胎培养物的帮助,可以开发动脉粥样硬化的基因治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号